Clinical trial management provider THREAD has partnered with Allucent, a consulting agency for clinical trials, to launch a decentralized clinical trial solution called "Allucent Patient Direct Trials." The platform will provide technology and regulatory expertise to small and emerging biotechnology companies, assisting with the design stage of clinical trials. The new platform will be paired with THREAD's and Allucent's consulting services to help clinical trial operators with aspects such as remote engagement and data collection.
Allucent is a global clinical trial consultant that assists small to medium-sized biotechnology companies. The company assists with issues related to protocol and study design, feasibility and study startup, patient recruitment, project management, clinical operations, centralized monitoring, decentralized trials, regulatory expertise, and biomedical drug development. The company is located across the US, UK, and Europe, consulting for companies across 60 countries.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.